Company: PDEX
Filing Date: 2025-01-30
Form Type: 10-Q
Source: 0001079973-25-000164
Chunk: 25

Company: PRO DEX INC
Filing Date: 2025-01-30
Form: 10-Q
Item: Item 2
Chunk 25
---
2,635  
     8% 
     2,195  
     9% 
     16% 
     20%
  
    Research
and development costs	 
     942  
     6% 
     788  
     6% 
     1,784  
     6% 
     1,593  
     7% 
     20% 
     12%

     2,380  
     14% 
     2,025  
     16% 
     4,517  
     14% 
     3,851  
     16% 
     18% 
     17%

Selling expenses consist
of salaries and other personnel-related expenses for our business development department, as well as advertising and marketing expenses,
and travel and related costs incurred in generating and maintaining our customer relationships. Selling expenses for the three and six
months ended December 31, 2024 increased $12,000 and $35,000, respectively, compared to the corresponding periods of fiscal 2024. The
increase in both periods is primarily due to recruiting fees related to our new Director of Business Development (who we hired in December,
2024).

General and administrative
expenses (“G&A”) consists of salaries and other personnel-related expenses of our accounting, finance and human resource
personnel, as well as costs for outsourced information technology services, professional fees, directors’ fees, and other costs
and expenses attributable to being a public company. G&A increased $189,000 and $440,000, respectively, during the three and six months
ended December 31, 2024, when compared to the corresponding periods of the prior fiscal year. The increases relate primarily to increased
bonus accruals and personnel costs, offset by decreased audit fees and stock compensation expense.

Research and development
costs generally consist of salaries, employer paid benefits, and other personnel- related costs of our engineering and support personnel,
as well as allocated facility and information technology costs, professional and consulting fees, patent-related fees, lab costs, materials,
and travel and related costs incurred in the development and support of our products. Research and development costs for the three and
six months ended December 31, 2024, increased $154,000 and $191,000, respectively, compared to the corresponding periods of the prior
fiscal year. The increase for the three months ended December 31